Apolipoprotein E ∈4 allele distributions in late-onset Alzheimer's disease and in other amyloid-forming diseases

No abstract is available for this paper.

• Publication year

  1993

• Venue

  The Lancet

• Publication date

  1993-09-18

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/0140-6736(93)91709-U
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Confirmation of association between the e4 allele of apolipoprotein E and Alzheimer's disease.

  1994cited by this paper
• Association of apolipoprotein E allele epsilon 4 with late-onset familial and sporadic Alzheimer's disease.

  1993cited by this paper
• The apolipoprotein ε4 allele in patients with Alzheimer's disease

  1993cited by this paper
• Apolipoprotein E: high-avidity binding to beta-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer disease.

  1993cited by this paper
• Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families.

  1993cited by this paper
• Apolipoprotein E: a pathological chaperone protein in patients with cerebral and systemic amyloid.

  1992cited by this paper
• Apolipoprotein E immunoreactivity in cerebral amyloid deposits and neurofibrillary tangles in Alzheimer's disease and kuru plaque amyloid in Creutzfeldt-Jakob disease.

  1991cited by this paper
• Alzheimer's Disease in the National Academy of Sciences Registry of Aging Twin Veterans

  1990cited by this paper

• Testing relevant difference in high-dimensional linear regression with applications to detect transferability

  2025cites this paper
• Clinical Significance of APOE4 Genotyping: Potential for Personalized Therapy and Early Diagnosis of Alzheimer’s Disease

  2025cites this paper
• Decreased Brain pH Correlated With Progression of Alzheimer Disease Neuropathology: A Systematic Review and Meta-Analyses of Postmortem Studies

  2024cites this paper
• Inflammasome signaling is dispensable for ß-amyloid-induced neuropathology in preclinical models of Alzheimer’s disease

  2024cites this paper
• Discovering Genetic Signatures Associated with Alzheimer's Disease in Tiled Whole Genome Sequence Data: Results from the Artificial Intelligence for Alzheimer's Disease (AI4AD) Consortium

  2024cites this paper
• Complement receptor 1 is expressed on brain cells and in the human brain

  2023cites this paper
• Neuronal APOE4-induced Early Hippocampal Network Hyperexcitability in Alzheimer’s Disease Pathogenesis

  2023cites this paper
• APOE4-promoted gliosis and degeneration in tauopathy are ameliorated by pharmacological inhibition of HMGB1 release

  2023cites this paper
• Exploring the diagnostic markers of essential tremor: A study based on machine learning algorithms

  2023cites this paper
• The neuroimmune axis of Alzheimer’s disease

  2023cites this paper
• Disclosure of Genetic Risk Factors for Alzheimer’s Disease to Cognitively Healthy Individuals—From Current Practice towards a Personalised Medicine Scenario

  2022cites this paper
• Alzheimer’s disease – the journey of a healthy brain into organ failure

  2022cites this paper
• The interaction and pathogenesis between cognitive impairment and common cardiovascular diseases in the elderly

  2022cites this paper
• Analysis of the time-dependent changes of phospholipids in the brain regions of a mouse model of Alzheimer's disease.

  2022cites this paper
• Independent APOE4 knock‐in mouse models display reduced brain APOE protein, altered neuroinflammation, and simplification of dendritic spines

  2022cites this paper
• Differential Neuropathology, Genetics, and Transcriptomics in Two Kindred Cases with Alzheimer’s Disease and Lewy Body Dementia

  2022cites this paper
• A Review of Oxidative Stress Products and Related Genes in Early Alzheimer’s Disease

  2021cites this paper
• Comparative analysis of Alzheimer’s disease knock-in model brain transcriptomes implies changes to energy metabolism as a causative pathogenic stress

  2021cites this paper
• The Amyloid-β Pathway in Alzheimer’s Disease

  2021cites this paper
• Stem cell-derived three-dimensional (organoid) models of Alzheimer’s disease: a precision medicine approach

  2021cites this paper
• The Alzheimer’s disease drug development landscape

  2021cites this paper
• The Impact of Complement Genes on the Risk of Late-Onset Alzheimer’s Disease

  2021cites this paper
• Forgot to Exercise? Exercise Derived Circulating Myokines in Alzheimer's Disease: A Perspective

  2021cites this paper
• Brain transcriptomes of zebrafish and mouse Alzheimer's disease knock-in models imply early disrupted energy metabolism

  2021cites this paper
• Drosophila as a model to study autophagy in neurodegenerative diseases and digestive tract

  2021cites this paper
• Therapeutic considerations for APOE and TOMM40 in Alzheimers disease: A tribute to Allen Roses MD

  2020cites this paper
• Apolipoprotein E Triggers Complement Activation in Joint Synovial Fluid of Rheumatoid Arthritis Patients by Binding C1q

  2020cites this paper
• Development of MALDI Mass Spectrometry Imaging Methods for Probing Spatial Lipid Biochemistry of Amyloid Plaques in Alzheimer's Disease

  2020cites this paper
• Intracerebral Expression of AAV-APOE4 Is Not Sufficient to Alter Tau Burden in Two Distinct Models of Tauopathy

  2020cites this paper
• A prospective cohort study of prodromal Alzheimer’s disease: Prospective Imaging Study of Ageing: Genes, Brain and Behaviour (PISA)

  2020cites this paper
• The multiplex model of the genetics of Alzheimer’s disease

  2020cites this paper
• Defining activation states of microglia in human brain tissue: an unresolved issue for Alzheimer’s disease

  2020cites this paper
• When lipid homeostasis runs havoc: lipotoxicity links lysosomal dysfunction to autophagy.

  2020cites this paper
• Sex modulates the ApoE ε4 effect on brain tau deposition measured by 18F-AV-1451 PET in individuals with mild cognitive impairment

  2019cites this paper
• Can Healthy Diets, Regular Exercise, and Better Lifestyle Delay the Progression of Dementia in Elderly Individuals?

  2019cites this paper
• KLOTHO heterozygosity attenuates APOE4-related amyloid burden in preclinical AD

  2019influential citation
• Brain ApoA-I, ApoJ and ApoE Immunodetection in Cerebral Amyloid Angiopathy

  2019cites this paper
• Related biomarkers of neurocognitive impairment in children with obstructive sleep apnea.

  2019cites this paper
• Benefits and Challenges of Rare Genetic Variation in Alzheimer’s Disease

  2019cites this paper
• Exploiting Drug-Apolipoprotein E Gene Interactions in Hypertension to Preserve Cognitive Function: The 3-City Cohort Study.

  2019cites this paper
• Putative Risk Factors for Alzheimer’s Disease

  2019cites this paper
• Pathway-Specific Genetic Risk for Alzheimer's Disease Differentiates Regional Patterns of Cortical Atrophy in Older Adults.

  2019cites this paper
• Targeted Lipidomics Investigation of N ‐acylethanolamines in a Transgenic Mouse Model of AD: A Longitudinal Study

  2019cites this paper
• Herpes Simplex Virus Vectors for Gene Transfer to the Central Nervous System

  2018cites this paper
• Genetic Study of Alzheimer’s Disease in Saudi Population

  2018cites this paper
• A Novel Association of Polymorphism in the ITGA4 Gene Encoding the VLA-4 α4 Subunit with Increased Risk of Alzheimer's Disease

  2018cites this paper
• Warning SINEs: Alu elements, evolution of the human brain, and the spectrum of neurological disease

  2018cites this paper
• Integrated analysis of human genetic association study and mouse transcriptome suggests LBH and SHF genes as novel susceptible genes for amyloid-β accumulation in Alzheimer’s disease

  2018cites this paper
• Neuropathology of Alzheimer’s disease in Down syndrome

  2018cites this paper
• Convergent molecular defects underpin diverse neurodegenerative diseases

  2018cites this paper
• The Biology of Glial Cells and Their Complex Roles in Alzheimer’s Disease: New Opportunities in Therapy

  2018cites this paper
• The age of onset and evolution of Braak tangle stage and Thal amyloid pathology of Alzheimer’s disease in individuals with Down syndrome

  2018cites this paper
• The emerging genetic landscape of cerebral palsy.

  2018cites this paper
• Overview of Alzheimer’s disease in Down syndrome

  2018cites this paper
• Abnormal Function of Metalloproteins Underlies Most Neurodegenerative Diseases

  2017cites this paper
• Role of BACE1 in Alzheimer’s synaptic function

  2017cites this paper
• Molecular Mechanisms of Synaptic Plasticity and Memory and Their Dysfunction in Alzheimer's Disease

  2017cites this paper
• Genetik und Gen-Umwelt-Interaktionen bei psychischen Erkrankungen

  2017cites this paper
• Hippocampal thinning linked to longer TOMM40 poly‐T variant lengths in the absence of the APOE ε4 variant

  2017cites this paper
• Clusterin in the Brain

  2017cites this paper
• Warning SINEs: Alu elements, evolution of the human brain, and the spectrum of neurological disease

  2017cites this paper
• ABCA1 Deficiency Affects Basal Cognitive Deficits and Dendritic Density in Mice

  2017cites this paper
• Hippocampal synaptic and neural network deficits in young mice carrying the human APOE4 gene

  2017cites this paper
• Apo E4 Alleles and Impaired Olfaction as Predictors of Alzheimer’s Disease

  2017cites this paper
• Bioactive Compound Screen for Pharmacological Enhancers of Apolipoprotein E in Primary Human Astrocytes.

  2016cites this paper
• Genetic and Functional Dissection of Age-Related Macular Degeneration

  2016cites this paper
• Epidemiology of Mental Disorders (Including Cross-Cultural Comparisons)

  2016cites this paper
• Clusterin (APOJ) in Alzheimer’s Disease: An Old Molecule with a New Role

  2016cites this paper
• Mitochondrial Regulatory Pathways in the Pathogenesis of Alzheimer’s Disease

  2016cites this paper
• The beginnings of Alzheimer’s disease: A review on inflammatory, mitochondrial, genetic and epigenetic pathways

  2016cites this paper
• Potential benefits of mindfulness-based interventions in mild cognitive impairment and Alzheimer's disease: an interdisciplinary perspective.

  2015cites this paper
• Opposing effects of Apoe/Apoa1 double deletion on amyloid-β pathology and cognitive performance in APP mice.

  2015cites this paper
• MRI-based brain atrophy rates in ADNI phase 2: acceleration and enrichment considerations for clinical trials

  2015cites this paper
• Interaction between years of education and APOE ε4 status on frontal and temporal metabolism

  2015cites this paper
• Role of apolipoprotein E polymorphism as a prognostic marker in traumatic brain injury and neurodegenerative disease: a critical review.

  2015influential citation
• Executive functioning and risk for Alzheimer's disease in the cognitively intact: Family history predicts Wisconsin Card Sorting Test performance.

  2015cites this paper
• Potential Natural Products for Alzheimer’s Disease: Targeted Search Using the Internal Ribosome Entry Site of Tau and Amyloid-β Precursor Protein

  2015cites this paper
• ApoE Type 4 Allele Affects Cognitive Function of Aged Population in Tianjin City, China

  2015cites this paper
• The Intersection of Genomics of Cardiometabolic Disease and Eye Health

  2015cites this paper
• Evaluation and management of patients with symptoms after anti-reflux surgery.

  2015cites this paper
• Homozygosity in the ApoE 4 polymorphism is associated with dysphagic symptoms in older adults.

  2015cites this paper
• Exercise, APOE genotype, and the evolution of the human lifespan.

  2014cites this paper
• Genetic variants conferring susceptibility to Alzheimer’s disease in the general population; do they also predispose to dementia in Down’s syndrome

  2014cites this paper
• Oxidative damage in Alzheimer’s disease

  2014cites this paper
• Pharmacogenomics in Drug Discovery and Development

  2014cites this paper
• APOE gene polymorphisms and susceptibility to Creutzfeldt-Jakob disease.

  2014cites this paper
• APOE ϵ4, rated life experiences, and affect among centenarians

  2014cites this paper
• Imaging Brain Effects of APOE4 in Cognitively Normal Individuals Across the Lifespan

  2014cites this paper
• Plasma insulin-degrading enzyme: Characterisation and evaluation as a potential biomarker for Alzheimer's disease

  2014cites this paper
• Predicting Cognitive Decline in Older Adults Through Multi-Voxel Pattern Analysis

  2014cites this paper
• The APOE ɛ4 allele affects complexity and functional connectivity of resting brain activity in healthy adults

  2014cites this paper
• Apolipoprotein ε4-Allele as a Significant Risk Factor for Conversion from Mild Cognitive Impairment to Alzheimer’s disease: a Meta-analysis of Prospective Studies

  2013cites this paper
• Unbiased tensor-based morphometry: Improved robustness and sample size estimates for Alzheimer's disease clinical trials

  2013cites this paper
• The Role of Apolipoprotein E Gene Polymorphisms in Primary Glaucoma and Pseudoexfoliation Syndrome

  2013cites this paper
• Conséquences de l'invalidation génétique et pharmacologique des récepteurs adénosinergiques A2A dans un modèle de pathologie Tau. Relation avec les aspects neuro-inflammatoires

  2013cites this paper
• Eradication of Helicobacter pylori Is Associated with the Progression of Dementia: A Population-Based Study

  2013cites this paper
• MALATTIA DI ALZHEIMER E DEGENERAZIONE LOBARE FRONTOTEMPORALE: RICERCA DI MUTAZIONI AUTOSOMICHE DOMINANTI E ANALISI GENETICA E FUNZIONALE DI GENI CANDIDATI

  2013cites this paper
• The pathophysiology of triose phosphate isomerase dysfunction in Alzheimer's disease.

  2013cites this paper
• Genotype-phenotype interactions in pediatric obstructive sleep apnea.

  2013cites this paper
• Atypical aging in Down syndrome.

  2013cites this paper